ERBB3 and neoplasm: The combination of 5-FU and oxaliplatin were shown to elevate the expression of tumour-promoting proteins, such as EGFR, HER2, human epidermal growth factor receptor 3 (HER3), Akt and COX2, which rendered the cell survival and uncontrolled cell proliferation in chemo-surviving cells.